Titan Pharmaceuticals Inc (TTNP)
6.70
0.00 (0.00%)
USD |
NASDAQ |
May 02, 16:00
Titan Pharmaceuticals Max Drawdown (5Y): 99.91% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 99.91% |
March 31, 2024 | 99.91% |
February 29, 2024 | 99.91% |
January 31, 2024 | 99.91% |
December 31, 2023 | 99.91% |
November 30, 2023 | 99.91% |
October 31, 2023 | 99.91% |
September 30, 2023 | 99.91% |
August 31, 2023 | 99.91% |
July 31, 2023 | 99.91% |
June 30, 2023 | 99.91% |
May 31, 2023 | 99.91% |
April 30, 2023 | 99.91% |
March 31, 2023 | 99.91% |
February 28, 2023 | 99.91% |
January 31, 2023 | 99.91% |
December 31, 2022 | 99.91% |
November 30, 2022 | 99.91% |
October 31, 2022 | 99.91% |
September 30, 2022 | 99.91% |
August 31, 2022 | 99.91% |
July 31, 2022 | 99.91% |
June 30, 2022 | 99.91% |
May 31, 2022 | 99.91% |
April 30, 2022 | 99.86% |
Date | Value |
---|---|
March 31, 2022 | 99.86% |
February 28, 2022 | 99.86% |
January 31, 2022 | 99.86% |
December 31, 2021 | 99.86% |
November 30, 2021 | 99.83% |
October 31, 2021 | 99.81% |
September 30, 2021 | 99.80% |
August 31, 2021 | 99.80% |
July 31, 2021 | 99.80% |
June 30, 2021 | 99.80% |
May 31, 2021 | 99.80% |
April 30, 2021 | 99.79% |
March 31, 2021 | 99.79% |
February 28, 2021 | 99.78% |
January 31, 2021 | 99.78% |
December 31, 2020 | 99.78% |
November 30, 2020 | 99.78% |
October 31, 2020 | 99.74% |
September 30, 2020 | 99.67% |
August 31, 2020 | 99.67% |
July 31, 2020 | 99.67% |
June 30, 2020 | 99.67% |
May 31, 2020 | 99.67% |
April 30, 2020 | 99.67% |
March 31, 2020 | 99.67% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
97.48%
Minimum
May 2019
99.91%
Maximum
May 2022
99.69%
Average
99.82%
Median
Max Drawdown (5Y) Benchmarks
Outset Medical Inc | -- |
Allurion Technologies Inc | -- |
AIM ImmunoTech Inc | 99.76% |
Protalix BioTherapeutics Inc | 94.35% |
Armata Pharmaceuticals Inc | 99.87% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -80.03 |
Beta (5Y) | 1.321 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 100.0% |
Historical Sharpe Ratio (5Y) | -0.6531 |
Historical Sortino (5Y) | -1.381 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 40.76% |